Healthcare Facilities company Aster DM Healthcare announced Q2FY25 & H1FY25 results Revenue: Revenue grew 18% YoY to Rs 2,088 crore. in H1FY25 v/s. Rs 1,772 crore. in H1FY24. Revenue grew 16% YoY to Rs 1,086 crore. in Q2FY25 v/s. Rs 934 crore. in Q2FY24. EBITDA: Operating EBITDA grew 44% YoY to Rs 410 crore. in H1FY25 v/s. Rs 285 crore. in H1FY24. Operating Margins stood at 19.6% in H1FY25 as compared to 16.1% in H1FY24. Operating EBITDA grew 48% YoY to Rs 233 crore. in Q2FY25 v/s. Rs 157 crore. in Q2FY24. Operating EBITDA Margins stood at 21.4% in Q2FY25 v/s. 16.8% in Q2FY24. Profits: PBT grew by 134% YoY to Rs 284 crore. in H1FY25 v/s. Rs 121 crore. in H1FY24. Net Profit (post NCI) grew by 88% to Rs 171 crore. in H1FY25 v/s. Rs 91 crore. in H1FY24. Azad Moopen, Founder and Chairman, Aster DM Healthcare, said: “We are pleased with the momentum built in the second quarter of FY25, which reflects our unwavering focus on operational excellence and capacity enhancement. In H1FY25, our India business achieved 18% YoY growth, reaching Rs 2,088 crore, driven by increased occupancy and growth in ARPOB. The Operating EBITDA grew by 44% YoY to Rs 410 crore and net profits (post NCI) grew by 88% YoY to Rs 171 crore in H1FY25. The steady growth across our core businesses, combined with strategic cost optimization, has significantly strengthened our margins with H1FY25 Operating EBITDA margins standing at 19.6%.” “As we expand, with plans to surpass ~6,800 beds by FY27, Aster DM Healthcare is well-positioned to meet the increasing demand for advanced healthcare in India. I am pleased to share that 9 Aster Hospitals are now accredited in the new Digital Standards Published by NABH signifying our commitment to Digital Transformation. Amongst them 5 Hospitals have been accorded highest accreditation in Platinum category thus underscoring our leadership in digital healthcare transformation.” Result PDF